SCHEMBL12323271

SCHEMBL12323271

CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4C[C@@H]5CCN(C)C[C@@H]5C4)cc3OC)nc2N1C1CCCC1

nearest known ligand 0.84

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 14/20 0.84
PLK1 P53350 13/20 0.84
PLK3 Q9H4B4 7/20 0.84
ALK Q9UM73 5/20 0.84
PLK2 Q9NYY3 5/20 0.84
TAF1 P21675 5/20 0.84
PRKD3 O94806 3/20 0.84
CLK2 P49760 3/20 0.84
PTK2 Q05397 3/20 0.84
CAMK2G Q13555 3/20 0.84
CAMK2D Q13557 3/20 0.84
PRKD2 Q9BZL6 3/20 0.84
CSNK1G1 Q9HCP0 3/20 0.84
CSNK1G3 Q9Y6M4 3/20 0.84
BRDT Q58F21 3/20 0.84
DAPK3 O43293 2/20 0.84
CHEK2 O96017 2/20 0.84
EGFR P00533 2/20 0.84
FES P07332 2/20 0.84
PHKG2 P15735 2/20 0.84

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12323834 1.00 BRD4 (0.84) BRD4PLK1PLK3ALKPLK2
SCHEMBL12324592 1.00 BRD4 (0.84) BRD4PLK1PLK3ALKPLK2
SCHEMBL12323289 1.00 BRD4 (0.84) BRD4PLK1PLK3ALKPLK2
SCHEMBL12323277 1.00 BRD4 (0.84) BRD4PLK1PLK3ALKPLK2
SCHEMBL12323293 1.00 BRD4 (0.84) BRD4PLK1PLK3ALKPLK2
SCHEMBL12323286 0.96 PLK1 (0.86) BRD4PLK1PLK3ALKPLK2
SCHEMBL12323269 0.96 PLK1 (0.86) BRD4PLK1PLK3ALKPLK2
SCHEMBL12323789 0.96 PLK1 (0.86) BRD4PLK1PLK3ALKPLK2
SCHEMBL13227794 0.93 BRD4 (0.92) BRD4PLK1PLK3ALKPLK2
Bi-2536 SCHEMBL372489 0.91 BRD4 (1.00) BRD4PLK1PLK3ALKPLK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011113293-A1 DIHYDROPTERIDINONE DERIVATIVES, PREPARATION METHOD AND PHARMACEUTICAL USE THEREOF 江苏恒瑞医药股份有限公司 (CN) 2011-09-22 WO disclosed